Trusted Network WCG IRB boasts a broad, credible network of partner institutions and AAHRPP-accredited panels, reinforced by a long track record. This makes it a premier partner for sponsors, CROs, and sites seeking high-quality ethical review. Use the trust and scale to cross-sell comprehensive IRB services and related quality and compliance offerings to mid-sized and large pharma, biotech, and medical device customers expanding their trials.

Digital Integration Recent digital initiatives show readiness to adopt and integrate regulatory tech, such as the eISF workflow integration with Complion to streamline document management across trial lifecycles. This openness signals opportunities to propose AI-assisted document review, digital trial master file optimization, and end-to-end regulatory information management services in collaboration with partner platforms.

Global Talent WCG IRB's international programs and global panel footprint indicate growing international trial activity and a sustained investment in leadership and staff development. This creates opportunities for training partnerships, staff augmentation, and global regulatory consulting with biotech, device, and diagnostic sponsors pursuing cross-border studies.

Cross Sell Potential As a gold standard in human subject protection with a broad WCG ecosystem, there are upsell opportunities beyond IRB review, including protocol and study-related review, safety monitoring services, and regulatory/compliance consulting. Focus on existing institutions and CROs to expand service scope within the network.

Tech Driven Trials The disclosed tech stack and recent product launches signal a push toward modernizing trial operations. There is room to offer tech-enabled trial optimization packages, cloud and security assessments, and managed services for IRB workflow automation and digital collaboration between sites and sponsors.